Nemonoxacin
Sponsors
TaiGen Biotechnology Co., Ltd., Zhejiang Medicine Co., Ltd., R-Pharm
Conditions
Community-acquired PneumoniaHealthy VolunteersKidney DysfunctionLiver DysfunctionPneumoniaPneumonia, Bacterial
Phase 1
Clinical Study on Oral Nemonoxacin Malate Capsules
CompletedNCT01395108
Start: 2008-01-31End: 2008-08-31Updated: 2011-07-15
Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function
CompletedNCT02604498
Start: 2016-04-14End: 2018-01-15Updated: 2018-03-30
Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function
NCT02840812
Start: 2017-04-05End: 2019-01-31Target: 24Updated: 2018-04-03
Phase 3
Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP
CompletedNCT01529476
Start: 2011-04-30End: 2012-12-31Updated: 2013-06-18
A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP
CompletedNCT02205112
Start: 2014-06-30End: 2017-05-15Updated: 2021-10-25
Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia
CompletedNCT03551210
Start: 2016-05-04End: 2017-12-26Updated: 2023-02-16